|
Address
|
H. Lundbeck A/S
Ottiliavej 9
DK-2500 Valby - Copenhagen
Denmark
Tel: +45 3630 1311
Fax: +45 3643 8262
information@lundbeck.com
Â
|
|
Media Relations
|
Jens Harder Højbjerg
Media Relations Manager
Tel:Â Â +45 3643 2833
Mob: +45 3083 2833
jehh@lundbeck.com
Mads Vindahl Kronborg
Communication Specialist
Tel:Â +45 3643 2851
Mob: +45 3083 2851
mavk@lundbeck.com
Anders Schroll
Head of Corporate Communication
Tel: +45 3643 2081
Mobile: +45 3083 2081
asch@lundbeck.com
Â
|
|
Profile
|
H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders.
Â
|
|
Board of Management
Â
|
Ulf Wiinberg, Chief Executive Officer
Anders Gersel Pedersen, Executive Vice President, Drug Development
Anders Götzsche, Executive Vice President, Chief Financial Officer
Lars Bang, Executive Vice President, Supply Operations & Engineering
Peter Høngaard Andersen, Executive Vice President, Research
Stig Løkke Pedersen, Executive Vice President, Commercial Operations
Â
|
|
Average number of employees
Â
|
2003Â Â 2004Â Â Â 2005Â Â Â 2006Â Â Â Â 2007
5,223Â Â 5,155Â Â 5,022Â Â 5,111Â Â Â 5,134
|
|
Revenue
Â
Â
|
DKK million
2003Â Â 2004Â Â 2005Â Â 2006Â Â Â 2007
9,941Â 9,733Â 9,070Â 9,221Â Â 10,985
|
|
Revenue by product
Â
|
Â
|
2007
|
|
Cipralex/Lexapro
Ebixa Â
Azilect
Other products  Â
Other revenue
All products brands are registered trade marks®
|
62%
16%
 2%
17%
 3%
Â
|
|
Revenue by market
Â
|
Europe                          Â
USAÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
International Markets       Â
Other revenue                  Â
|
2007
51%
25%
21%
 3%
Â
|
Profit from operations
|
DKK million
2003Â Â 2004Â Â 2005Â Â Â 2006Â Â Â 2007
2,147Â 2,554Â 2,170Â Â 1,784Â Â 2,695
Â
|
| R&D costs |
DKK million   Â
2003Â Â 2004Â Â 2005Â Â 2006Â Â 2007
1,931Â 1,776Â 1,782Â 1,958Â 2,187
Â
|
|
% of revenue
|
19%Â Â Â 18%Â Â Â 20%Â Â Â 21%Â Â 20%
|
|